Literature DB >> 16485046

Demographics, treatment and outcome of acute coronary syndromes: 17 years of experience in a specialized cardiac centre.

Jean-Pierre S Awaida1, Jocelyn Dupuis, Pierre Théroux, Guy Pelletier, Michel Joyal, Pierre De Guise, Serge Doucet, Luc Bilodeau, Bernard Thibault, Jean-Francois Tanguay, Richard Gallo, Jean Grégoire, Philippe L L'Allier, Laurent Macle, Anil Nigam.   

Abstract

BACKGROUND: Epidemiological information on patients with acute coronary syndromes managed in specialized cardiac centres is limited.
OBJECTIVE: To report the evolution of demographics, treatment and outcome of patients admitted to a tertiary coronary care unit (CCU) over a 17-year period.
METHODS: A prospective database of 18,719 patients admitted from April 1986 to March 2003 in a 21-bed CCU was analyzed.
RESULTS: From 1986 to 2003, the number of admissions increased from 937 to 1577 per year, while the length of stay declined from 7.5 to 3.5 days. The mean age increased from 58.4 to 63.4 years, and the proportion of men remained stable at approximately 70%. The use of coronary angiograms increased from 49.8% to 81.1% in all patients, while fibrinolysis dropped to 0.4%. In-hospital mortality decreased from 9% to 1.5%. The percentage of overall instrumentation (arterial line, central venous catheter, temporary pacemaker, Swan-Ganz catheter and intra-aortic balloon pump) decreased from 38% to 8.1%. From 1995 to 2003, the proportion of stenting during percutaneous transluminal coronary angioplasty increased dramatically from 0% to 86%. In the past five years, surgical revascularization has remained stable at approximately 20% of all admissions. The proportion of patients discharged with a noncoronary chest pain diagnosis has remained constant at approximately 4%.
INTERPRETATION: There has been a tremendous increase in efficiency, with an approximate doubling of the admissions turnover rate in a tertiary CCU. Patients with acute coronary syndromes are stratified faster and treated more invasively. Therapeutic advances are reflected by an almost linear 0.5% per year decrease in in-hospital mortality.

Entities:  

Mesh:

Year:  2006        PMID: 16485046      PMCID: PMC2538994          DOI: 10.1016/s0828-282x(06)70250-1

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  16 in total

1.  Progress in the treatment of acute coronary syndromes: a 50-year perspective (1950-2000).

Authors:  P Théroux; J T Willerson; P W Armstrong
Journal:  Circulation       Date:  2000-11-14       Impact factor: 29.690

2.  A contemporary overview of percutaneous coronary interventions. The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR).

Authors:  H Vernon Anderson; Richard E Shaw; Ralph G Brindis; Kathleen Hewitt; Ronald J Krone; Peter C Block; Charles R McKay; William S Weintraub
Journal:  J Am Coll Cardiol       Date:  2002-04-03       Impact factor: 24.094

Review 3.  Need for centers to care for patients with acute coronary syndromes.

Authors:  Robert M Califf; David P Faxon
Journal:  Circulation       Date:  2003-03-25       Impact factor: 29.690

4.  Editor's commentary: centers of excellence.

Authors:  James T Willerson
Journal:  Circulation       Date:  2003-03-25       Impact factor: 29.690

Review 5.  Regionalization of care for acute ischemic heart disease: a call for specialized centers.

Authors:  Eric J Topol; Dean J Kereiakes
Journal:  Circulation       Date:  2003-03-25       Impact factor: 29.690

6.  Prolonged hospital stay after acute myocardial infarction: assessing the evidence.

Authors:  Elliot J Smith; Martin T Rothman; Adam D Timmis
Journal:  Lancet       Date:  2004-02-14       Impact factor: 79.321

7.  Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators.

Authors: 
Journal:  Lancet       Date:  1999-08-28       Impact factor: 79.321

8.  Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina.

Authors:  K A A Fox; P A Poole-Wilson; R A Henderson; T C Clayton; D A Chamberlain; T R D Shaw; D J Wheatley; S J Pocock
Journal:  Lancet       Date:  2002-09-07       Impact factor: 79.321

9.  International differences in evolution of early discharge after acute myocardial infarction.

Authors:  Padma Kaul; L Kristin Newby; Yuling Fu; Daniel B Mark; Robert M Califf; Eric J Topol; Phil Aylward; Christopher B Granger; Frans Van de Werf; Paul W Armstrong
Journal:  Lancet       Date:  2004-02-14       Impact factor: 79.321

10.  Risk stratification, management and outcomes of patients with non-ST elevation acute coronary syndrome: a Canadian teaching hospital perspective.

Authors:  Yana Shamiss; Yaariv Khaykin; John Papastergiou; Katy Shufelt; Mina Madan; Eric A Cohen; Fran L Paradiso-Hardy
Journal:  Can J Cardiol       Date:  2003-08       Impact factor: 5.223

View more
  3 in total

1.  Characteristics, treatment and one-year outcomes of patients with acute coronary syndrome in a tertiary hospital in India.

Authors:  Simeon Isezuo; Vijayakumar Subban; Jaishankar Krishnamoorthy; Ulhas Madhukarrao Pandurangi; Ezhilan Janakiraman; Latchumanadhas Kalidoss; Mullasari Ajit Sankardas
Journal:  Indian Heart J       Date:  2013-12-22

2.  Enduring somatic threat perceptions and post-traumatic stress disorder symptoms in survivors of cardiac events.

Authors:  Laura Meli; Carmela Alcántara; Jennifer A Sumner; Brendan Swan; Bernard P Chang; Donald Edmondson
Journal:  J Health Psychol       Date:  2017-04-27

Review 3.  Posttraumatic stress disorder prevalence and risk of recurrence in acute coronary syndrome patients: a meta-analytic review.

Authors:  Donald Edmondson; Safiya Richardson; Louise Falzon; Karina W Davidson; Mary Alice Mills; Yuval Neria
Journal:  PLoS One       Date:  2012-06-20       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.